Alimentary protein deficiency aggravates mitochondrial dysfunction in animals with acetaminophen-induced kidney injury

Authors

DOI:

https://doi.org/10.12923/cipms-2025-0028

Keywords:

acetaminophen, kidney, mitochondria, low protein diet

Abstract

We investigated the indicators of kidney function, the degree of ROS-mediated damage to lipids and proteins of mitochondria, the activity of antioxidant enzymes and the I and II complexes of the respiratory chain enzymes in animals with APAP-induced kidney damage and alimentary protein deficiency. Accordingly, in rats with APAP kidney toxic injury against protein deficiency, one of the mechanisms of impaired kidney function is the activation of oxidative damage to mitochondrial biomolecules. This is followed by a dysfunction of mitochondrial complexes I (NADH dehydrogenase: ubiquinone oxidoreductase) and II (succinate: ubiquinone oxidoreductase), and leads to histopathological changes in the kidney structure. Our work demonstrated that protein deficiency in the diet is a critical factor in determining the degree of structural and functional changes in the kidneys in animals with APAP kidney injury. The obtained results substantiate the rationale for assessing the organism’s supply of protein when developing a plan for nephrotoxicity management in patients with an acute acetaminophen overdose.

References

1. Kanchanasurakit S, Arsu A, Siriplabpla W, Duangjai A, Saokaew S. Acetaminophen use and risk of renal impairment: A systematic review and meta-analysis. Kidney Res Clin Pract. 2020;39:81-92.

2. Mostafa EMA, Tawfik AM, Abd-Elrahman KM. Egyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: Lessons learnt during COVID-19 pandemic. Toxicol Rep. 2022;9:541-8.

3. Roy S, Pradhan S, Das K, Mandal A, Mandal S, Patra A, et al. Acetaminophen induced kidney failure in rats: a dose response. J Biol Sci. 2015;15:187-93.

4. Naggayi M, Mukiibi N, Iliya E. The protective effects of aqueous extract of Carica papaya seeds in paracetamol induced nephrotoxicity in male wistar rats. Afr Health Sci. 2015;15:598-605.

5. Shao QH, Yin XD, Liu HX, Zhao B, Huang JQ, Li ZL. Kidney injury following ibuprofen and acetaminophen: a real-world analysis of post-marketing surveillance data. Front Pharmacol. 2021;12:750108.

6. Hall AM, Schuh CD. Mitochondria as therapeutic targets in acute kidney injury. Curr Opin Nephrol Hypertens. 2016;25:355-62.

7. Perazella MA. Pharmacology behind Common Drug Nephrotoxicities. Clin J Am Soc Nephrol. 2018;13:1897-08.

8. El-Hashash SA, Gaballah WA, Faramawy AA, Rizk NI, Alsuwat MA, Alshehri MA, et al. Mitigating acetaminophen-induced Kidney Injury: The protective role of grape seed and peanut skin extracts through the iNOS/CYP2E1 pathway. ACS Omega. 2024;9(32): 35154-69.

9. Reeves P, Nielsen F, Fahey G. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent. J Nutr. 1993;123(11):1939-51.

10. Gao Y, Cao Z, Yang X, Abdelmegeed MA, Sun J, Chen S, et al. Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury. Proteomics Clin Appl. 2017;11:10.1002/prca.201600123.

11. Ruiz-Ramírez A, Barrios-Maya M, Quezada-Pablo H, López-Acosta O, El-Hafidi M. Kidney dysfunction induced by a sucrose-rich diet in rat involves mitochondria ROS generation, cardiolipin changes, and the decline of autophagy protein markers. Am J Physiol Renal Physiol. 2020;318:F53-F66.

12. Rodrigues T, de França LP, Kawai C, de Faria PA, Mugnol KC, Braga FM, et al. Protective role of mitochondrial unsaturated lipids on the preservation of the apoptotic ability of cytochrome C exposed to singlet oxygen. J Biol Chem. 2007;282:25577-87.

13. Voloshchuk OM, Kopylchuk GP, Mishyna YI. Аctivity of the mitochondrial isoenzymes of endogenous aldehydes catabolism under the conditions of acetaminophen-induced hepatitis. Ukr Biochem J. 2018;90:42-7.

14. Parihar MS, Pandit MK. Free radical induced increase in protein carbonyl is attenuated by low dose of adenosine in hippocampus and mid brain: implication in neurodegenerative disorders. Gen Physiol Biophys. 2003;22: 29-39.

15. Voloshchuk OM, Ursatyy МS, Kopylchuk GP. The NADH-ubiquinone reductase and succinate dehydrogenase activity in the rat kidney mitochondria under the conditions of different protein and sucrose content in the diet. Ukr Biochem J. 2022;94:105-13.

16. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247:3170-5.

17. Hadwan MH, Abed HN. Data supporting the spectrophotometric method for the estimation of catalase activity. Data Brief. 2015;6: 194-9.

18. Grivennikova VG, Kapustin AN, Vinogradov AD. Catalytic activity of NADH-ubiquinone oxidoreductase (complex I) in intact mitochondria. evidence for the slow active/inactive transition. J Biol Chem. 2001;276:9038-44.

19. Ahmad F, Alamoudi W, Haque S, Salahuddin M, Alsamman K. Simple, reliable, and timeefficient colorimetric method for the assessment of mitochondrial function and toxicity. Bosn J Basic Med Sci. 2018;18:367-74.

20. Naughton СА. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78:743-50.

21. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008;4:2-6.

22. Fotheringham AK, Solon-Biet SM, Bielefeldt-Ohmann H, McCarthy DA, McMahon AC, Ruohonen K, et al. Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure. iScience. 2021;24:103308.

23. Hiragi S, Yamada H, Tsukamoto T, Yoshida K, Kondo N, Matsubara T, et al. Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study. Clin Epidemiol. 2018;10: 265-76.

24. Ściskalska M, Śliwińska-Mossoń M, Podawacz M, Sajewicz W, Milnerowicz H. Mechanisms of interaction of the N-acetyl-p-aminophenol metabolites in terms of nephrotoxicity. Drug Chem Toxicol. 2015;38:121-5.

25. Ahmed OM, Fahim HI, Ahmed HY, Mahmoud B, Aljohani SAS, Abdelazeem WH. The nephropreventive and antioxidant effects of navel orange peel hydroethanolic extract, naringin and naringenin in n-acetyl-p-aminophenol-administered wistar rats. Adv Anim Vet Sci. 2018;6:96-105.

26. Mancinelli E, Shaw DJ, Meredith AL. γ-Glutamyl-transferase (GGT) activity in the urine of clinically healthy domestic rabbits. Vet Rec. 2012;171:475.

27. Crivellenti LZ, Mesa JS, Meirelles AE, Borin Crivellenti S, Mireya EG, Canola JC, et al. False positivity of gamma-glutamyl transpeptidase measurement inurine. Ren Fail. 2014;36:581-4.

28. Hua H, Ge X, Wu M, Zhu C, Chen L, Yang G, et al. Rotenone protects against acetaminophen-induced kidney injury by attenuating oxidative stress and inflammation. Kidney Blood Press Res. 2018;43: 1297-09.

29. Mandal A, Patra A, Mandal S, Roy S, Mahapatra SD, Mahapatra TD, et al. Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats. Clin Exp Nephrol. 2015;19:168-77.

30. Kopylchuk GP, Voloshchuk OM. Peculiarities of the free radical processes in rat liver mitochondria under toxic hepatitis on the background of alimentary protein deficiency. Ukr Biochem J. 2016; 88(2):66-72.

31. Ding W, Xu C, Wang B, Zhang M. Rotenone attenuates renal injury in aldosterone-infused rats by inhibiting oxidative stress, mitochondrial dysfunction, and inflammasome activation. Med Sci Monit. 2015;21:3136-43.

32. Sun Y, Zhang Y, Zhao D, Ding G, Huang S, Zhang A, Jia Z. Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathy. Mediators Inflamm. 2014;2014:670106.

33. Braga PC, Alves MG, Rodrigues AS, Oliveira PF. Mitochondrial pathophysiology on chronic kidney disease. Int J Mol Sci. 2022; 23:1776.

Downloads

Published

2025-08-12

How to Cite

Voloshchuk, O., & Kopylchuk, H. (2025). Alimentary protein deficiency aggravates mitochondrial dysfunction in animals with acetaminophen-induced kidney injury. Current Issues in Pharmacy and Medical Sciences, 38(3 (AOP). https://doi.org/10.12923/cipms-2025-0028